REVIEWS |
|
Gmoshinskaya M.V., Pyryeva E.A.
Breastfeeding: yesterday and today
|
6-10 |
|
Vorobyeva I.N., Gmoshinskaya M.V., Aleshina I.V.
An interdisciplinary approach to breastfeeding support
|
11-15 |
|
Pshenichnikova I.I., Zakharova I.N., Borzakova S.N., Pupykina V.V., Osmanov I.M.
Ezetimibe in the treatment of dyslipidemia in children and adolescents with types 1 and 2 diabetes mellitus: efficacy and safety
|
16-23 |
|
Krasilnikova S.V., Gorbunova K.V., Eliseeva T.I., Bulgakova V.A.
Endotypic heterogeneity of chronic rhinosinusitis
|
24-30 |
|
Karpova E.P., Belov V.A., Asmanov A.I., Tulupov D.A., Naumov O.G.
Current approaches to the treatment of acute rhinosinusitis in children in outpatient practice
|
31-38 |
|
Mashanskaya A.V., Vlasenko A.V., Belogorova T.A., Berdina O.N., Bugun O.V., Rychkova L.V.
Home-based rehabilitation programs for children with cerebral palsy: validity, feasibility, and effectiveness (literature review)
|
39-47 |
|
Pshenichnikova I.I., Zakharova I.N., Borzakova S.N., Belozerova A.D., Osmanov I.M.
Smoker’s cough in adolescents: pathogenesis, clinical features and use of butamirate
|
48-55 |
|
Orlova E.A., Kulieva O.A., Kandrashkina Yu.A., Levashova O.A., Nikolashina O.E., Rybalkin S.B.
The role of skin microbiota in the development of atopic dermatitis in pregnant women and their newborns: prospects for diagnosis and therapy
|
56-60 |
|
Macharadze D.Sh.
New treatment options for severe atopic dermatitis: upadacitinib. Review
|
62-68 |
|
Antonova A.A., Yamanova G.A., Murzova O.A., Abdurakhimova P.M.
Alagille syndrome: current understanding of pathogenesis, diagnostic and treatment issues (literature review)
|
70-75 |
|
Sysoeva A.S., Orlova E.A., Levashova O.A., Kulieva O.A., Kandrashkina Yu.A.
The role of intestinal microbiota in the development of atopic dermatitis
|
76-82 |
|
Antonova A.A., Yamanova G.A., Belyakova I.S., Tarasochkina D.S.
Clinical description and genetic nature of Patau syndrome (trisomy 13). Literature review
|
83-88 |
|
Vlasova A.V., Kameneva T.R., Yakovlev S.V.
Promising directions for the use of intravenous fosfomycin in children
|
89-96 |
|
|
Shatalina S.I., Aksenova M.B., Kolosova N.G., Kasanave E.V., Aseeva E.V.
Combination drugs in the treatment of cough in acute respiratory viral infections occurring with bronchial obstruction
|
97-104 |
|
Botkina A.S., Gumennaya E.R.
Clinical experience with methylprednisolone aceponate for atopic dermatitis in young children
|
106-114 |
|
Latyshev O.Yu., Okminyan G.F., Kiseleva E.V., Samsonova L.N.
Prevention of diseases associated with vitamin D deficiency in children: an analysis of the Endocrine Society guidelines (2024)
|
115-122 |
ORIGINAL ARTICLES |
|
Vorobyova O.A., Drozdov V.N., Kazakov R.E., Fedorova T.A., Shikh E.V.
Modifiable and non-modifiable risk factors for vitamin d deficiency in infants and young children
|
123-130 |
|
Meskina E.R., Khadisova M.K., Tselipanova E.E., Galkina L.A.
Comparative efficacy of two broad-spectrum antiviral drugs universally used for the treatment of COVID-19 in children
|
131-140 |
|
Ivaschenko D.V., Aysin F.R., Byalkovskaya P.A., Gragyants B.R., Shevchenko Yu.S., Sychev D.A.
Age-specific safety of pharmacotherapy for behavioral disorders in children and adolescents: a retrospective study
|
141-151 |
|
|
Bogdanyants M.V., Cholukova L.A.
A clinical case of acute lymphoblastic leukemia in a child in a district covered by childhealth care
|
152-156 |
|
Donyush E.K., Zhironkina A.B.
Experience with selumetinib in a patient with neurofibromatosis type 1 and inoperable pelvic plexiform neurofibroma: a case report
|
157-162 |
|
Ishbuldina A.V., Vakhitov K.M., Sabirova D.R., Karpova O.A., Shaimardanova G.R.
Clinical case of ROHHAD syndrome in pediatric practice
|
163-168 |
Русский
